e-ISSN: Pending
Negative / Null Result ReportOpen accessVeterinary medicine

Effects of intravenous administration of peripheral blood‐derived mesenchymal stromal cells after infusion of lipopolysaccharide in horses

Sandra D. Taylor; Priscila B. S. Serpa; Andrea P. Santos; Kelsey A. Hart; Sarah A. Vaughn; George E. Moore; Abhijit Mukhopadhyay; Allen E. Page · 2022 · Journal of Veterinary Internal Medicine

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract Background A systemic and dysregulated immune response to infection contributes to morbidity and mortality associated with sepsis. Peripheral blood‐derived mesenchymal stromal cells (PB‐MSC) mitigate inflammation in animal models of sepsis. Allogeneic PB‐MSC administered IV to horses is well‐tolerated but therapeutic benefits are unknown. Hypothesis After IV lipopolysaccharide (LPS) infusion, horses treated with PB‐MSC would have less severe clinical signs, clinicopathological abnormalities, inflammatory cytokine gene expression, and oxidative stress compared to controls administered

Abstract by Sandra D. Taylor; Priscila B. S. Serpa; Andrea P. Santos; Kelsey A. Hart; Sarah A. Vaughn; George E. Moore; Abhijit Mukhopadhyay; Allen E. Page, Journal of Veterinary Internal Medicine (2022) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1111/jvim.16447